Compare ARK Genomic Revolution ETF (ARKG) vs Charles Schwab Corporation Common Stock (SCHW) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Charles Schwab Corporation Common Stock — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while Charles Schwab Corporation Common Stock trades at $103.55 (market cap $179.34B). The key difference: Charles Schwab Corporation Common Stock pays a 1.24% dividend while ARK Genomic Revolution ETF pays none. Which is the better fit depends on your goals.
| ARKG | SCHW | |
|---|---|---|
Sector | Sector/Thematic | Financials |
52-Week High | $43.57 | $107.21 |
52-Week Low | $23.09 | $85.35 |
Market Cap | — | $179.34B |
Dividend Yield | — | 1.24% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Charles Schwab (SCHW) trades at $103.12, up 1.19% today, near its pivot point of $102 with bullish technical momentum. The stock shows strong fundamentals with a 37.99% net income margin and 21.79% ROE, supported by three consecutive quarterly earnings beats. Recent news highlights a Zacks upgrade to Strong Buy and a four-year high in the Schwab Trading Activity Index, reflecting robust retail engagement.
Outlook remains positive with a consensus price target of $122.71 implying 19% upside, though overbought RSI signals near-term caution. Risks include interest rate sensitivity and competitive pressures, but institutional bullishness and expanding prediction market initiatives offer growth catalysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Charles Schwab Corporation Common Stock
Charles Schwab operates in brokerage, banking, and asset-management businesses. The company runs a large network of brick-and-mortar brokerage branch offices, a well-established online investing website, and has mobile trading capabilities. It also operates a bank and a proprietary asset management business and offers services to independent investment advisors. The company is among the largest firms in the investment business, with over $8 trillion of client assets at the end of 2021. Nearly all of its revenue is from the United States.
Read more on SCHW →
